Skip to Main Content
Contact Us

Helping to Bring Hematologic Oncology Therapies to Cancer Patients in Need

Andrew Zupnick, PhD
April 18, 2024

Catalyst Oncology is a niche oncology clinical research organization (CRO) devoting time, energy, and capital to supporting biotechs in bringing next-generation hematologic oncology (heme/onc) therapies to cancer patients in need. Clinical trials in hematologic malignancies are complex, more so than in solid tumors and thus require a higher level of expertise in your CRO partner. Bringing effective heme/onc therapies to proof-of-concept and then to market as fast as possible is our mission because every second counts for patients and their families living with blood cancer. 

Active portfolio in a range of hematologic oncology trials

We understand the nuances of hematologic oncology trials

Active next-generation oncology experience

Working largely in early- to mid-phase development across a range of both solid and hematologic indications, we understand the nuances of complex study designs, novel endpoints, and cutting-edge technologies.